Sign in Pull a receipt

BLTE

BELITE BIO, INC

Healthcare · Biotechnology

$192.64 sample

-0.64 (-0.33%) 1D

Market cap

$658.6B

Price as of

2026-10-29

Latest filing

8-K · 2026-09-10

Alerts

8

Price$192.64 -6.75% 3M daily closessample

208.22183.84

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider buy: 10% owner
Oct 14INSInsider sell: Chief Executive Officer
Oct 07INSInsider sell: 10% owner
Sep 28INSInsider buy: EVP, Operations
Sep 18INSInsider sell: Director
Sep 10SECDEF 14A filed
Sep 01INSInsider buy: 10% owner
Aug 21INSInsider sell: 10% owner

Sign up to see the real BLTE record →

Company facts

SEC EDGAR registration

Name: BELITE BIO, INC
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -1sample, -100 to +100
Reporting currency: USD

Who is positioning in BLTE

sample

Insiders: 29 insider transactions over 90 days, net selling, $355.7M
Congress: 4 members traded over 90 days
Institutions · 13F: 33 funds hold $10.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$37.7B +15.5% y/y

Q4 2024Q3 2026

Inventory$22.5B +8.7% y/y

Q4 2024Q3 2026

Accounts receivable$16.6B +9.2% y/y

Q4 2024Q3 2026

Total debt$47.2B +17.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $238.8B +8.4% 3M
Sample peer B: $228.1B +5.5% 3M
Sample peer C: $117.8B -3.0% 3M
Sample peer D: $394.4B -5.9% 3M
Sample peer E: $280.7B +12.7% 3M